Page results
-
UCLH has declared a climate and health emergency, and has published a 10-point climate action plan to reach net zero carbon dioxide emissions by 2031.
-
Information about our UCLH Charity, charity funds and associated charities.
-
Having proton beam therapy under general anaesthetic: information for children aged 5-8 patient information
-
Having proton beam therapy under general anaesthetic: information for children aged 1- 4 patient information
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
UCLH will play a vital role in a new respiratory virus study.
-
UCLH is continuing to scale up the number of services that offer Advice & Guidance, as well as identifying various improvements within the existing Advice & Guidance service. Over the last few months, UCLH has introduced 5 new specialties to the service, with additional specialties due to go live shortly.
-
Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.
-
The Royal National ENT Voice Centre is a national and international multidisciplinary centre for voice disorders. The voice clinic at the RNENT is one of the oldest in the UK.
File results
-
FOI/2023/0579 - Procurement for specialist seating for patients
-
FOI/2023/0581 - Treatment of Haemophilia
-
FOI/2023/0586 - Children treated for E-scooter injuries
-
FOI/2023/0589 - International nurse recruitment
-
FOI/2023/0591 - Healthcare Assistants agency rates 2023
-
FOI/2023/0592 - Procurement staff organisation chart
-
FOI/2023/0603 - Treatment of dermatological conditions
-
FOI/2023/0604 - Patient flow system
-
FOI/2023/0609 - Companies that currently have contracts at UCLH
-
FOI/2023/0613 - Treatment for Melanoma